Hunan Runchu Marketing Service Co., Ltd.

Hunan Runchu Marketing Service Co., Ltd. is a professional promoter of therapeutic drugs. Founded in December 2015, it is one of the earliest specialized CSO companies in China. The company is located in Changsha Headquarters Base, with its own office space of about 2,000 square meters, providing a spacious and comfortable office environment. It currently has more than 100 employees with social insurance, most of whom graduated from medicine-related majors and possess experience and capabilities in drug promotion. They are passionate and enterprising, making the company one of the drug promotion enterprises with the largest number of employees in Hunan Province. The company has advanced marketing concepts and a standardized and well-established management system. It has built a strong, professional academic promotion network covering about 3,500 hospital terminals across the province, providing promotion and marketing services for many multinational companies and domestic listed companies, including the top three global generic drug sellers: Viatris and Sandoz; and domestic listed companies: Fudan Fuhua, CONBA, Jiudian Pharmaceutical, Renhe Pharmacy, etc. The company adheres to its unique "Four-Wheel Operation Model": professionally selected products drive sustainable market expansion, efficient service drives in-depth cooperation, commercial collaboration drives broad coverage, and academic promotion drives high per-unit output. The company carefully selects products that align with industry development trends and have therapeutic value. Specific types include: original research drugs, centralized procurement drugs, nationally negotiated drugs, essential drugs, medical insurance drugs, etc. It is the exclusive promotion service provider for Viatris in Hunan's broad market and the first enterprise in Hunan to undertake academic promotion of centralized procurement varieties, with successful experience. Representative centralized procurement products include Hengluokai-Candesartan Cilexetil Tablets, selected in the second batch of national centralized procurement; Shandekang-Pantoprazole Sodium Enteric-coated Tablets and Jiudian-Loxoprofen Sodium Tablets, selected in the fourth batch of national centralized procurement; Shangruiyou-Ibandronate Sodium Injection, Changran-Ebastine Tablets, and Gute-Ornidazole Tablets, selected in the seventh batch of national centralized procurement; and provincial alliance centralized procurement selected products Duomengte-Alanyl Glutamine Injection, Shukeyi-Hydrotalcite Chewable Tablets, and Meinuohua-Perindopril Tert-Butylamine Tablets, promoting faster and broader access of centralized procurement varieties to patients. The company adheres to a product line focus strategy: the main product lines are hepatobiliary and digestive, cardiovascular, and orthopedics, with representative products including Glutathione, Octreotide, Lipitor, Norvasc, Celebrex, etc., aiming to assist clinical doctors in providing optimal treatment plans for patients. The company has always upheld the business purpose of "integrity-based" and the service concept of "moistening things silently": providing customers with attentive, meticulous, and efficient services, gaining customer support and trust, and earning a good reputation in the industry. The company works closely with mainstream distribution businesses in Hunan to comprehensively and timely cover medical institutions at all levels within the province. The company adheres to an academic-oriented approach, actively carrying out various academic activities, and providing professional academic services for clinical practice. The company aims to become a nationally renowned professional CSO company, committed to building a shared platform that realizes the value of customers, suppliers, and employees, and contributing to the healthy development of the pharmaceutical industry!